Contact UsInvestorsCareersMediaScienceContact Us
HomeResponsibilityEquitable Access to MedicinesGlobal Aid and Emergency ReliefGlobal Aid and Emergency ReliefAround the world, Pfizer aims to work closely with governments and non-governmental organisations (NGOs) to enable prevention and treatment of disease by making medicines, vaccines and over-the-counter products available to as many people as possible. 

Recognising the critical need to provide ongoing aid as well as emergency humanitarian relief, Pfizer has a three part approach, including medicine donations, cash grants, and other access programmes.

Medicine Donations

Pfizer believes that medicine donations play an important role in supporting communities around the world. Most of Pfizer’s product donations, which are managed through established NGO partners, are designed to address an expressed need, providing underserved communities with access to potentially life-saving medicines and vaccines.

For example, to support the global strategy towards attempting to eliminate blinding trachoma by the year 2030,1 Pfizer has worked with the International Trachoma Initiative (ITI) and the World Health Organization (WHO) since 1998 by providing antibiotic donations.2

Here in the UK, we've been supporting the International Health Partners, Europe’s largest coordinator of donated healthcare products, for more than 15 years. Find out more.

Cash Grants

In an effort to reach as many people as possible, we support a number of organisations responding to global disasters such as earthquakes, disease outbreaks and humanitarian crises.

In recent years, The Pfizer Foundation* and Pfizer have provided cash grants to various NGOs providing aid during emergencies such as the refugee crisis in Europe and the Middle East, the Zika outbreak, and Hurricane Matthew in Haiti and the United States.

Humanitarian Assistance Programmes

Every day, Pfizer colleagues around the world work collaboratively with governments, non-governmental organisations (NGOs), Civil Service Organisations (CSOs), healthcare providers, and payers to help provide countries with access to our medicines, vaccines and products through our humanitarian assistance programmes.

For example, through a collaboration with Gavi, the Vaccine Alliance, we are helping to broaden access to vaccines across the world's poorest countries. Additionally, Pfizer believes that to tackle some of the health challenges faced in low-income countries, we must look beyond access to medicines and help address the need for greater education amongst the health care workers at the forefront of delivering care.

*The Pfizer Foundation is a charitable organisation established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.


International Trachoma Initiative

The International Trachoma Initiative aims to meet the WHO's call to eliminate trachoma by 2030.


Medicines Donations

We have been a proud supporter of International Health Partners (IHP) for around 15 years.


Gavi, and the vaccine alliance

In 2010, Pfizer embarked on a partnership called the Advance Market Commitment (AMC) with Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation, and donor governments.


  1. World Health Organization. 'Trachoma factsheet'. Last accessed May 2024.
  2. International Trachoma Initiative. Last accessed May 2024.
PP-UNP-GBR-9246 / May 2024
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.